Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio tracy Thu, 03/23/2017 – 16:29 More: Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio Source: fierce
read moreValeant awarded CEO Papa $62.7M last year despite missing financial targets chelfand Thu, 03/23/2017 – 11:31 More: Valeant awarded CEO Papa .7M last year despite missing financial targets Source: fierce
read moreIt’s not just lower U.S. drug prices Trump wants. He wants the lowest, period esagonowsky Thu, 03/23/2017 – 10:33 More: It's not just lower U.S. drug prices Trump wants. He wants the lowest, period Source: fierce
read moreWarning letter follows ban for Chinese API maker Jinan Jinda Pharmaceutical epalmer Thu, 03/23/2017 – 10:04 More: Warning letter follows ban for Chinese API maker Jinan Jinda Pharmaceutical Source: fierce
read moreSanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source aliu Thu, 03/23/2017 – 09:34 More: Sanofi on verge of B-plus deal for arthritis-focused biotech Flexion: source Source: fierce
read moreAn experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration. More: Shire’s rare blood disorder drug gets
read more© 1994 - 2026 B.M. Pharmaceuticals